ARCHIVES

Also Cancer incidence, mortality level off after declines in 1990s.

This article is from The Cancer Letter archive.

Vol. 29 No. 33 | September 12, 2003

Download PDF Visit The Full Archive

Related Articles

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

Recompetition of $1.9 Mil. Primate Contract Approved

November 15, 1985

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

NSABP Submits Appeal To NIH To Reverse Cancellation Of P-4 Chemoprevention Trial.

August 10, 2007

How NCI’s Plans For Software Giveaway Sank In Scientific And Legal Disputes (Part Two In A Series About NCI’s Bioinformatics Venture caBIG).

March 4, 2011

Letters to the Editor: Us Too! Objects to ODAC Member’s Comments; Brawley Responds

March 28, 2003